Holdings of Biotechnology Fund
Rydex Variable Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 10.7M $ including 10.6M $ in equities, 99.6 %
- Positions
- 72 in 9 countries
- Top ten
- 37.0 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | AbbVie Inc | 3,661 | 796.2K $ | 7.46 % |
| 2 | Amgen Inc | 1,602 | 563.7K $ | 5.28 % |
| 3 | Gilead Sciences Inc | 3,830 | 533.8K $ | 5.00 % |
| 4 | Vertex Pharmaceuticals Inc | 966 | 431.4K $ | 4.04 % |
| 5 | Regeneron Pharmaceuticals, Inc. | 496 | 383.2K $ | 3.59 % |
| 6 | Alnylam Pharmaceuticals Inc | 848 | 280.6K $ | 2.63 % |
| 7 | Insmed Inc | 1,616 | 264.2K $ | 2.48 % |
| 8 | BEONE MEDICINES LTD | 829 | 246.2K $ | 2.31 % |
| 9 | Natera Inc | 1,128 | 225.6K $ | 2.11 % |
| 10 | United Therapeutics Corp | 376 | 223K $ | 2.09 % |
| 11 | Biogen Inc | 1,180 | 216.3K $ | 2.03 % |
| 12 | Royalty Pharma PLC | 4,443 | 213.1K $ | 2.00 % |
| 13 | Illumina Inc | 1,519 | 187.2K $ | 1.75 % |
| 14 | Revolution Medicines Inc | 1,871 | 182K $ | 1.71 % |
| 15 | Moderna Inc | 3,493 | 177.4K $ | 1.66 % |
| 16 | AstraZeneca PLC | 875 | 172.6K $ | 1.62 % |
| 17 | Argenx SE | 236 | 172.3K $ | 1.62 % |
| 18 | Incyte Corp | 1,779 | 167.4K $ | 1.57 % |
| 19 | Viatris Inc | 11,963 | 161.6K $ | 1.51 % |
| 20 | Bridgebio Pharma Inc | 2,134 | 158.5K $ | 1.49 % |
| 21 | Alkermes PLC | 4,470 | 158.1K $ | 1.48 % |
| 22 | Jazz Pharmaceuticals PLC | 833 | 157.5K $ | 1.48 % |
| 23 | Neurocrine Biosciences Inc | 1,158 | 152.6K $ | 1.43 % |
| 24 | Guardant Health Inc | 1,643 | 151.8K $ | 1.42 % |
| 25 | Roivant Sciences Ltd | 5,450 | 151K $ | 1.42 % |
| 26 | Ionis Pharmaceuticals Inc | 1,983 | 148.9K $ | 1.40 % |
| 27 | Exelixis Inc | 3,237 | 138.8K $ | 1.30 % |
| 28 | Medpace Holdings Inc | 282 | 135.4K $ | 1.27 % |
| 29 | BioMarin Pharmaceutical Inc | 2,371 | 133.9K $ | 1.26 % |
| 30 | Apellis Pharmaceuticals Inc | 3,277 | 131.8K $ | 1.24 % |
| 31 | Arrowhead Pharmaceuticals Inc | 2,102 | 131.8K $ | 1.24 % |
| 32 | Cytokinetics Inc | 1,921 | 126.6K $ | 1.19 % |
| 33 | Vaxcyte Inc | 2,103 | 122.2K $ | 1.15 % |
| 34 | CRISPR Therapeutics AG | 2,555 | 121.5K $ | 1.14 % |
| 35 | Halozyme Therapeutics Inc | 1,811 | 117K $ | 1.10 % |
| 36 | BioNTech SE | 1,288 | 114.5K $ | 1.07 % |
| 37 | Axsome Therapeutics Inc | 651 | 110K $ | 1.03 % |
| 38 | Ascendis Pharma A/S | 476 | 108.9K $ | 1.02 % |
| 39 | Cogent Biosciences Inc | 2,770 | 106.6K $ | 1.00 % |
| 40 | Arcellx Inc | 928 | 106.6K $ | 1.00 % |
| 41 | TG Therapeutics Inc | 3,127 | 103.9K $ | 0.97 % |
| 42 | PTC Therapeutics Inc | 1,509 | 102.8K $ | 0.96 % |
| 43 | Scholar Rock Holding Corp | 2,063 | 101.4K $ | 0.95 % |
| 44 | Madrigal Pharmaceuticals Inc | 186 | 97.4K $ | 0.91 % |
| 45 | Mirum Pharmaceuticals Inc | 1,043 | 96.4K $ | 0.90 % |
| 46 | Protagonist Therapeutics Inc | 893 | 94.1K $ | 0.88 % |
| 47 | Amicus Therapeutics Inc | 6,081 | 87.9K $ | 0.82 % |
| 48 | Rhythm Pharmaceuticals Inc | 969 | 84.3K $ | 0.79 % |
| 49 | Apogee Therapeutics Inc | 962 | 81K $ | 0.76 % |
| 50 | Kymera Therapeutics Inc | 929 | 77.4K $ | 0.73 % |
| 51 | Twist Bioscience Corp | 1,599 | 76K $ | 0.71 % |
| 52 | Viking Therapeutics Inc | 2,334 | 75.9K $ | 0.71 % |
| 53 | Summit Therapeutics Inc | 3,923 | 74.4K $ | 0.70 % |
| 54 | Nuvalent Inc | 722 | 74K $ | 0.69 % |
| 55 | ACADIA Pharmaceuticals Inc | 3,242 | 72.2K $ | 0.68 % |
| 56 | Travere Therapeutics Inc | 2,412 | 71.7K $ | 0.67 % |
| 57 | Sarepta Therapeutics Inc | 3,207 | 69.8K $ | 0.65 % |
| 58 | Celcuity Inc | 611 | 69.7K $ | 0.65 % |
| 59 | Arcutis Biotherapeutics Inc | 2,943 | 69.3K $ | 0.65 % |
| 60 | Veracyte Inc | 2,127 | 68.5K $ | 0.64 % |
| 61 | Liquidia Corp | 1,765 | 66.6K $ | 0.62 % |
| 62 | Beam Therapeutics Inc | 2,543 | 60.6K $ | 0.57 % |
| 63 | Ultragenyx Pharmaceutical Inc | 2,714 | 56.9K $ | 0.53 % |
| 64 | Praxis Precision Medicines Inc | 167 | 53.8K $ | 0.50 % |
| 65 | GRAIL Inc | 1,023 | 52.9K $ | 0.50 % |
| 66 | Soleno Therapeutics Inc | 1,567 | 52.5K $ | 0.49 % |
| 67 | Recursion Pharmaceuticals Inc | 16,655 | 51.1K $ | 0.48 % |
| 68 | Krystal Biotech Inc | 197 | 50.9K $ | 0.48 % |
| 69 | Intellia Therapeutics Inc | 3,943 | 50.5K $ | 0.47 % |
| 70 | LEGEND BIOTECH CORP | 2,794 | 50.5K $ | 0.47 % |
| 71 | ADMA Biologics Inc | 5,232 | 47.1K $ | 0.44 % |
| 72 | Akero Therapeutics Inc | 1,848 | 0.2 $ |
Sector breakdown
- Health care 48.1 %
- Unattributed 51.9 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 88.6 %
- Ireland 3.0 %
- United Kingdom 1.6 %
- Netherlands 1.6 %
- Bermuda 1.4 %
- Switzerland 1.1 %
- Germany 1.1 %
- Denmark 1.0 %
- Cayman Islands 0.5 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 63 | 9.4M $ | 88.64 % |
| 2 | Ireland | 2 | 315.5K $ | 2.97 % |
| 3 | United Kingdom | 1 | 172.6K $ | 1.62 % |
| 4 | Netherlands | 1 | 172.3K $ | 1.62 % |
| 5 | Bermuda | 1 | 151K $ | 1.42 % |
| 6 | Switzerland | 1 | 121.5K $ | 1.14 % |
| 7 | Germany | 1 | 114.5K $ | 1.08 % |
| 8 | Denmark | 1 | 108.9K $ | 1.02 % |
| 9 | Cayman Islands | 1 | 50.5K $ | 0.48 % |
Cite this page
Titelia. "Holdings of Biotechnology Fund". https://titelia.com/en/funds/S000003711